Biotech Acquisition (BIOT)
NASDAQ: BIOT
· Real-Time Price · USD
10.15
-0.08 (-0.78%)
At close: Feb 02, 2023, 10:00 PM
Company Description
Biotech Acquisition Company does not have significant operations.
It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other business combination with one or more businesses.
The company was incorporated in 2020 and is based in New York, New York.
Biotech Acquisition
| Country | United States |
| IPO Date | Mar 18, 2021 |
| Industry | Shell Companies |
| Sector | Financial Services |
| Employees | n/a |
| CEO | Michael Shleifer |
Contact Details
Address: 545 West 25th Street New York City, New York United States | |
| Website | n/a |
Stock Details
| Ticker Symbol | BIOT |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001825413 |
| CUSIP Number | G1125A108 |
| ISIN Number | KYG1125A1085 |
| Employer ID | 00-0000000 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Dr. Michael Shleifer Ph.D. | Chairman & Chief Executive Officer |
| Ivan Jarry | Chief Operating Officer |
| Thomas Fratacci | Chief Financial Officer & Treasurer |
| Albert F. Hummel M.B.A. | Chief Investment Officer & Director |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Feb 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Feb 14, 2023 | 15-12G | Filing |
| Feb 14, 2023 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Feb 14, 2023 | SC 13G | Statement of acquisition of beneficial ownership b... |
| Feb 13, 2023 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Feb 13, 2023 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Feb 02, 2023 | 25-NSE | Filing |
| Feb 02, 2023 | 8-K | Current Report |
| Jan 27, 2023 | SC 13G | Statement of acquisition of beneficial ownership b... |
| Jan 25, 2023 | 8-K | Current Report |